1. Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. (9th January 2023) Authors: Li, Fenglin; Ling, Qing; Lian, Jiaying; Chen, Ying; Hu, Chao; Yang, Min; Zhang, Xiang; Li, Chenying; Mao, Shihui; Ye, Wenle; Li, Xia; Lin, Xiangjie; Wei, Wenwen; Huang, Xin; Pan, Jiajia; Qian, Yu; Wang, Jinghan; Lu, Ying; Jin, Jie Journal: Cancer medicine Issue: Volume 12:Number 7(2023) Page Start: 8319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗